Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714063 · ClinicalTrials.gov registry record
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
A clinical trial, sponsored by Philips Respironics.
- Completed
- Registry status
- 34
- Enrollment target
NCT01714063 is a clinical trial that has completed, run by Philips Respironics. The registered enrollment target is 34 participants.
The verdict
NCT01714063 has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine ex vivo the amount of fluticasone deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond Valved Holding Chamber (VHC) mouthpiece and the subject's mouth during coordinated and uncoordinated actuation/inhalation maneuver.
Interventions
- DEVICE Pressurized Metered-Dose Inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714063
The ClinicalTrials.gov registry entry for NCT01714063 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pressurized Metered-Dose Inhaler is the first listed.
NCT01714063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714063 about?
NCT01714063 is a clinical study titled "Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use". The primary objective of this study is to determine ex vivo the amount of fluticasone deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond Valved Holding Chamber (VHC) mouthpiece and the subject's mouth during coordinated and uncoordinated actuation/inhalation maneuver...
What is the current status of trial NCT01714063?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2012-12. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01714063?
The interventions under investigation include: Pressurized Metered-Dose Inhaler (DEVICE).
Who is sponsoring clinical trial NCT01714063?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.